Beach 'may never be safe for swimming'
The beach at Heacham near Hunstanton has been classified as poor by the Environment Agency since 2021, with the cause of the problem being disputed among experts and locals.
After another "poor" result, Sandra Squire, cabinet member for environment at West Norfolk Council, admitted the coastal waters off Heacham may always have high levels of pollution.
Studies suggest 60% of the intestinal enterococci (IE) bacteria recorded in human and animal waste may be coming from seabirds, which visit The Wash in huge numbers throughout the year.
IE is the main bacteria causing the problems at Heacham, which is found in human and animal waste and, if ingested, can cause severe stomach upsets.
Scientists are yet to gather a full picture of the sources of poor water quality at Heacham, but sewage leaks/outfalls, agricultural run-off and dog waste are all cited as contributing factors.
Squire told a full council meeting that seabirds may always cause issues at Heacham.
"Sooner or later we may have to admit, if 60% of pollution is coming from the bird population, it may be that this area should not be for bathing," she said.
While DNA evidence suggests seabirds are a major cause, bacteria levels are highest in July and August, said the Local Democracy Reporting Service.
Squire suggested that increase could be due to numerous factors, ranging from increased tourism, less or more rainfall or due to birds breeding.
To better understand the problems, she called for year-round testing at Heacham, as currently it is only conducted in the summer months.
The meeting heard that Anglian Water has said its sewage works was nearing capacity and would not be able to cope with any more housing development.
Squire said: "If Anglian Water said they cannot cope, then nothing else should be connected to that sewage works.
"We all know what happens when they can't cope - we end up with sewage in our streets, our rivers and seas."
The Environment Agency told the BBC: "Pollution comes in many forms and from multiple sources, and the Environment Agency will continue to investigate poor water quality."
Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
Bird mess a factor as beach earns a 'brown flag'
Rising fees make beach huts 'hard to keep or sell'
Borough Council of King's Lynn & West Norfolk
Environment Agency
Local Democracy Reporting Service
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Go to the beach, just don't get wet. Bacteria warnings issued ahead of July 4th at 8 beaches
With the Fourth of July weekend, local beach lovers are ready to hit the shores. Authorities, however, are warning visitors to avoid any beach activities that involve getting wet at eight beaches. The warnings have been issued ahead of the holiday weekend due to excessive bacterial levels, county officials said. The Los Angeles County Public Health Department released a statement on Wednesday warning residents to avoid surfing, swimming and any other ocean-water activity after tests indicated that street runoff had increased bacterial levels at certain beaches. 'Swimming in water with bacteria can make you sick or cause skin infections,' the department said in astatement. 'Children, the elderly, and those who have weak immune systems are at higher risk of getting sick or infected.' The department could not estimate when the warnings would be lifted, but state law requires weekly tests be conducted on the waters. The following beaches were affected: · Avalon Beach at Catalina Island: the swimming area 50 feet west of Green Pleasure Pier and the Step Beach swim area east of the Casino arch. · Santa Monica Beach: Santa Monica North Lifeguard Tower 12 and 100 yards up and down the coast from the Wilshire Boulevard storm drain. · Ramirez Creek at Paradise Cove in Malibu: 100 yards up and down the coast from the pier. · Will Rogers State Beach: 100 yards up and down coast from the Bel Air Bay Club border fence. · Mothers Beach in Marina Del Rey: the entire swim area. · Topanga Beach: 100 yards up and down the coast from the Castlerock storm drain. · Santa Monica Beach: 100 yards up and down the coast from the Santa Monica Pier. · Inner Cabrillo Beach in San Pedro: the entire swim area. The health department will issue updates as they become available. Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week. This story originally appeared in Los Angeles Times.
Yahoo
3 hours ago
- Yahoo
UK Government to introduce new digital system for NHS
The UK Government has announced a strategy to expedite technology access across the National Health Service (NHS) with a new digital system. This initiative aims to reduce bureaucratic challenges and enhance life science through a streamlined process. The forthcoming 'innovator passport', set to launch over the next two years, will enable technologies assessed by one NHS organisation to be implemented by others. This is a focal point of the government's Plan for Change and its ten-year vision for health, which seeks to shape an NHS that is ready for the future. Complex procedures and slow approval times have previously deterred businesses from engaging with the NHS. The new system is set to eliminate these barriers, enabling organisations to collaborate with the NHS. A 'one-stop shop' thorough check will allow businesses to promptly commence operations across the nation. NHS patients will therefore benefit from quicker access to more effective treatments and support. The 'innovator passport' will eliminate the need for multiple compliance assessments, lessening redundancy within the health service. MedTech Compass, a digital platform developed by the Department of Health and Social Care (DHSC), will facilitate the delivery of the passport. Health and Social Care Secretary of State Wes Streeting said: 'These innovator passports will save time and reduce duplication, meaning our life sciences sector, a central part of our 10-Year Health Plan, can work hand-in-hand with the health service and make Britain a powerhouse for medical technology.' This platform will also support the Life Sciences Sector Plan, part of the industrial strategy designed to improve Britain's life sciences sector. Once a healthcare tool is evaluated by one NHS organisation, other organisations will no longer require repeated assessments, allowing local systems to conserve resources previously spent on duplicative bureaucratic processes. "UK Government to introduce new digital system for NHS" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
6 hours ago
- Yahoo
Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy
Belite Bio has completed enrolment in the 24-month PHOENIX Phase III trial assessing the tolerability and safety of oral Tinlarebant in individuals with geographic atrophy (GA) in dry age-related macular degeneration (AMD). This multicentre, randomised, placebo-controlled, double-masked, global trial is crucial in evaluating the therapy's potential to minimise the atrophic lesion growth rate in these patients. It has enrolled 500 participants across various sites in the US, the UK, the Czech Republic, France, Switzerland, Taiwan, Australia, and China. Tinlarebant, a one-daily tablet, is being developed as an early intervention to preserve retinal tissue health and integrity in those with Stargardt disease type 1 (STGD1) and GA. At present, there are no treatments approved by the Food and Drug Administration (FDA) for STGD1 and no approved oral treatments for GA. The tablet has received fast track, rare paediatric disease, and breakthrough therapy designations in the US, orphan drug status in the US, Japan, and Europe, and Sakigake designation in Japan for STGD1. Tinlarebant is also being evaluated in a Phase III trial (DRAGON) and a Phase II/III trial (DRAGON II) for adolescent STGD1 individuals, in addition to the PHOENIX trial for GA subjects. Belite Bio CEO and chairman Dr Tom Lin said: 'Completing enrolment in the PHOENIX trial marks an important milestone for Belite Bio as we advance our lead candidate, Tinlarebant, for the treatment of geographic atrophy. 'This achievement brings us one step closer to evaluating the potential of Tinlarebant to slow atrophic lesion growth in this serious and progressive disease for which there are no approved oral treatments. There remains a significant unmet need for this patient population.' The company develops new treatments for degenerative retinal diseases like STGD1 and GA. Last year, the company submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to initiate a trial of Tinlarebant for adolescent STGD1 treatment. "Enrolment concludes in Belite Bio's trial of Tinlarebant for geographic atrophy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio